December 17, 2019
FRAMINGHAM, MA, USA – December 17, 2019 – Alira Health, a leading international healthcare and life sciences advisory firm, announced that it has acquired Wellmera, a healthcare consulting firm headquartered in Basel, Switzerland specializing in market access for the pharmaceutical and biotechnology industries. The acquisition will bring global expertise in market access, pricing and reimbursement, health economics, and real-world evidence to Alira Health’s suite of healthcare advisory services.
The collective organization will advance Alira Health’s mission of enabling healthcare transformation by supporting clients across their product and corporate life cycles, with services in product development, regulatory, clinical, strategic consulting, and transaction advisory. The Wellmera team brings a wealth of experience in helping clients develop evidence, devise pricing and market access approaches, and provide tailored strategies to local client affiliates in preparation for pricing and reimbursement negotiations around the world, with a focus on European markets.
Jean-François Ricci will become Executive Vice President of Market Access and will lead Alira Health’s Market Access practice, covering pharma, biotech, and digital health in Europe and the United States.
Wellmera is a dynamic international consulting firm focused on market access, pricing and reimbursement, health economics, and real-world evidence. We help life sciences companies demonstrate value, optimize patient access, and realize the commercial opportunity for their products throughout the lifecycle.
Wellmera was established in 2011 in Basel, Switzerland and expanded in early 2018 to the US with offices in Cambridge, MA, and San Francisco, CA, leveraging synergies for global clients between Europe and the US.
Subscribe to our newsletter for the latest news, events, and thought leadership